B. Riley Securities Initiates Coverage On Exagen with Buy Rating, Announces Price Target of $15
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
B. Riley Securities analyst Anderson Schock initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price Target of $15.
B. Riley Securities analyst Anderson Schock initiates coverage on Exagen (NASDAQ:XGN) with a Buy rating and announces Price Target of $15.